最高の卵巣癌医師 - トップ121名の医師

Prof. Dr. Bülent Karagöz は、アナドル医療センターにて腫瘍生物学と免疫療法を専門とし、33年の経験 の医療腫瘍学の経験を持つ卵巣癌の専門家です。

• 権威あるGATA Haydarpaşa研修病院における腫瘍内科部長
• がん研究分野における40本以上の論文著者
• イスタンブール・オカン大学医学部教授
• トルコ腫瘍内科学会会員

エダ・タンリクル医師は、アナドル医療センターにて腫瘍内科および化学療法を専門とし、卵巣癌の治療に注力しています。

• マルマラ大学にて腫瘍内科の研修を修了
• 腫瘍学における国際臨床試験を主導
• 癌症例に関する多職種レビューチームに参加
• ハイダルパシャ・ヌムネ研修研究病院にて腫瘍内科部長を歴任

900件以上の手術実績 – ヤルチンカヤ医師は、アナドル医療センターにおける婦人科腫瘍学の専門家です。

• 婦人科および婦人科腫瘍学における20年の経験年の診療経験
• 卵巣癌症例を専門とする准教授
• 包括的な医療提供のための多職種腫瘍チームに所属
• ケアの質に関する患者評価：4.6

ハジェテペ大学癌研究所にてフェローシップを修了 – Solak医師は卵巣癌の診断と治療を専門としています。

• テキサス大学MDアンダーソン癌センターにて研修を修了
• 卵巣癌の複雑な症例を担当
• イスタンブール・シシュリ・エトファル研修研究病院にて研修医課程を修了
• ハジェテペ大学同窓会ネットワークの会員

Dr. Gorkem Turkkan is a radiation oncologist at Hisar Hospital Intercontinental in Istanbul. He has successfully completed over 2,500 radiotherapy sessions using MR-Linac technology. Dr. Turkkan focuses on MRI-guided radiotherapy and stereotactic treatments for various cancers. He conducted clinical research on proton therapy at the MAASTRO Clinic in the Netherlands.

• Specializes in prostate, breast, lung, and head and neck cancer treatments.
• Uses VMAT and IMRT techniques to target tumors with precision.
• Maintains membership in the European Society of Radiotherapy and Oncology.
• Works at a JCI-accredited hospital serving 500,000+ patients annually.

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Cem Iyibozkurt教授は、イスタンブール・フローレンス・ナイチンゲール病院において、卵巣癌に対する低侵襲手術およびロボット手術を専門としています。

• 婦人科腫瘍学における31年の経験年以上の経験
• フロリダ病院（オーランド）にてロボット手術の研修を修了
• イスタンブール大学にて分子医学の博士号取得
• 欧州婦人科腫瘍学会会員

Specialist in Oncological Gynecology and Radiotherapy

オーストリア最大の腫瘍科を率い、ウィーン包括がんセンターを設立。免疫療法および精密医療の個別化において世界的な第一人者である。

• 腫瘍内科学および血液学における40年以上の臨床経験
• 中欧協同腫瘍学グループ（CECOG）会長を歴任
• ウィーナー・プリヴァートクリニク国際腫瘍センター長
• ウィーン医科大学正教授および元腫瘍科部長

メフメット・カラジャ教授は、メディカルパーク・アンタルヤ病院複合施設において、高度な腹腔鏡技術を用いた婦人科がんを専門としています。

• 産科・婦人科における31年の経験年以上の診療経験
• 保健省による婦人科腫瘍外科の専門研修修了
• ハイリスク妊娠および骨盤底機能障害（女性骨盤底医学）における専門的知識
• 産科・婦人科学博士号取得

卵巣癌の第一人者であり、肉腫および骨腫瘍学に深い専門知識を持つメリムスキー博士は、スーラスキー医療センターの腫瘍科外来クリニックを統括しています。

• 腫瘍学における41年の経験以上の経験を有し、複雑な症例を専門とする
• 軟部組織・骨腫瘍ユニット長
• ワイツマン科学研究所およびフェルセンスタイン医学研究センター上席研究員
• ESMO軟部組織・骨肉腫ファカルティメンバー
• 癌の研究と治療に関する論文を多数発表

Dr. Altay Aliyev is a clinical oncologist at Liv Bona Dea Hospital Baku. He specializes in chemotherapy, immunotherapy, and targeted treatments for various cancers. Dr. Aliyev completed a fellowship as a research associate at the Cleveland Clinic. He treats complex conditions like glioblastoma, metastatic breast cancer, and colorectal tumors.

• Expertise covers cytotoxic chemotherapy, hormone therapy, and palliative oncological care.
• Published research on tumor markers in thyroid cancer and breast cancer chemotherapy.
• Formerly served as a research associate in the Cleveland Clinic Endocrinology Department.
• Practices at Liv Bona Dea Hospital, a JCI-accredited facility in Azerbaijan.

Dr. Rana Niftaliyeva is an oncologist-mammologist at the Biological Medicine Integrative Health Center in Baku. She specializes in breast cancer treatment and precancerous mammary gland diseases. Dr. Niftaliyeva has participated in medical conferences across Azerbaijan, Germany, and Turkey. She focuses on integrative approaches to cancer care.

• Treats large breast cysts using non-surgical aspiration techniques.
• Provides mistletoe therapy and high-dose vitamin C cancer treatments.
• Manages side effects of chemotherapy and radiation through supportive care.
• Performs biopsies and hormonal therapy for various oncological conditions.

Dr. Enrique Grande is a renowned medical oncologist at Hospital Ruber Internacional in Madrid. He has authored over 300 peer-reviewed scientific publications. Dr. Grande focuses on genitourinary and rare endocrine tumors. He serves as a pioneer in precision oncology and molecular profiling.

• Directs the Medical Oncology Department at QuirónSalud.
• Treats complex cases of bladder, kidney, and prostate cancers.
• Contributes to international guidelines for ESMO and ASCO.
• Leads global clinical trials to set new cancer care standards.

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Dr. David Kuczer is a radiation oncologist at Amethyst Radiotherapy in Vienna. He specializes in precise cancer treatment for tumors of the prostate, breast, and brain. Dr. Kuczer presents every patient case to an interdisciplinary tumor board. This ensures each person receives a validated treatment plan from a team of experts.

• Uses the Elekta Versa HD linear accelerator for precise tumor targeting.
• Treats complex conditions including glioblastoma, lung cancer, and meningioma.
• Coordinates care within a clinic ranked among Newsweek's World's Best Hospitals 2026.
• Provides IMRT, VMAT, and stereotactic radiosurgery for high-accuracy radiation.

Dr. Shira Felder leads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior radiation oncologist specializing in gynecologic and urologic cancers. She trained at the Princess Margaret Cancer Centre in Toronto. Dr. Felder focuses on delivering targeted radiation while preserving her patients' quality of life.

• Uses precision techniques including VMAT, IMRT, SBRT, and brachytherapy.
• Treats cervical, uterine, ovarian, and prostate cancers.
• Maintains membership in the European Society for Radiotherapy & Oncology.
• Works at Sheba Medical Center, ranked 7th globally by Newsweek.
• Conducts research on brachytherapy safety and cervical cancer survival.

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.